Abigail Wilpers

Abigail Wilpers

Auto-generated profile, based on publicly available information

Abigail Wilpers

Department of Family and Community Health, University of Pennsylvania School of Nursing, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in American Journal of Obstetrics & Gynecology MFM
Verified
Journal Article
Closed access
AWAbigail Wilpers
Abigail Wilpers
MBMert Ozan Bahtiyar
Mert Ozan Bahtiyar
DSDavid Stitelman
David Stitelman
JBJanene Batten
Janene Batten
RCRoberto X. Calix
Roberto X. Calix
GNGina Novick
Gina Novick

Verified
Journal Article
Open access
PDF file
LTLisanne Tollenaar
Lisanne Tollenaar
Enrico LoprioreEnrico Lopriore
Enrico Lopriore
SFStefano Faiola
Stefano Faiola
MLMariano Lanna
Mariano Lanna
JSJulien Stirnemann
Julien Stirnemann
FSFemke Slaghekke
Femke Slaghekke
The aim of this study was to investigate the management and outcome in the post-laser twin anemia polycythemia sequence (TAPS). Data of the international TAPS Registry, collected between 2014 and 2019, were used for this study. The primary outcomes were perinatal mortality and severe neonatal morbidity. Secondary outcomes included a risk factor analysis for perinatal mortality and severe neonatal morbidity. A total of 164 post-laser TAPS pregnancies were included, of which 92% (151/164) were diagnosed antenatally and 8% (13/164) postnatally. The median number of days between laser for TTTS and detection of TAPS was 14 (IQR: 7–28, range: 1–119). Antenatal management included expectant management in 43% (62/151), intrauterine transfusion with or without partial exchange transfusion in 29% (44/151), repeated laser surgery in 15% (24/151), selective feticide in 7% (11/151), delivery in 6% (9/151), and termination of pregnancy in 1% (1/151). The median gestational age (GA) at birth was 31.7 weeks (IQR: 28.6–33.7; range: 19.0–41.3). The perinatal mortality rate was 25% (83/327) for the total group, 37% (61/164) for donors, and 14% (22/163) for recipients (p < 0.001). Severe neonatal morbidity was detected in 40% (105/263) of the cohort and was similar for donors (43%; 51/118) and recipients (37%; 54/145), p = 0.568. Independent risk factors for spontaneous perinatal mortality were antenatal TAPS Stage 4 (OR = 3.4, 95%CI 1.4-26.0, p = 0.015), TAPS donor status (OR = 4.2, 95%CI 2.1–8.3, p < 0.001), and GA at birth (OR = 0.8, 95%CI 0.7–0.9, p = 0.001). Severe neonatal morbidity was significantly associated with GA at birth (OR = 1.5, 95%CI 1.3–1.7, p < 0.001). In conclusion, post-laser TAPS most often occurs within one month after laser for TTTS, but may develop up to 17 weeks after initial surgery. Management is mostly expectant, but varies greatly, highlighting the lack of consensus on the optimal treatment and heterogeneity of the condition. Perinatal outcome is poor, particularly due to the high rate of perinatal mortality in donor twins.

10 March 2022 in Fetal Diagnosis and Therapy
Verified
Journal Article
Open access
PDF file
AWAbigail Wilpers
Abigail Wilpers
ALAnna Y. Lynn
Anna Y. Lynn
BEBarbara Eichhorn
Barbara Eichhorn
APAmy B. Powne
Amy B. Powne
MLMegan Lagueux
Megan Lagueux
CGCary P. Gross
Cary P. Gross
Background/Purpose: Although maternal-fetal surgery to treat fetal anomalies such as spina bifida continues to grow more common, potential health disparities in the field remain relatively unexamined. To address this gap, we identified maternal-fetal surgery studies with the highest level of evidence and analyzed the reporting of participant sociodemographic characteristics and representation of racial and ethnic groups. Methods: We conducted a systematic review of the scientific literature using biomedical databases. We selected randomized control trials (RCTs) and cohort studies with comparison groups published in English from 1990 to May 5, 2020. We included studies from across the globe that examined the efficacy of fetal surgery for twin-twin transfusion syndrome (TTTS), obstructive uropathy, congenital diaphragmatic hernia (CDH), myelomeningocele (MMC), thoracic lesions, cardiac malformations, or sacrococcygeal teratoma. We determined the frequency of reporting of age, gravidity/parity, race, ethnicity, education level, language spoken, insurance, income level, and relationship status. We identified whether sociodemographic factors were used as inclusion or exclusion criteria. We calculated the racial and ethnic group representation for studies in the USA using the participation-to-prevalence ratio (PPR). Results: We included 112 studies (10 RCTs, 102 cohort) published from 1990–1999 (8%), 2000–2009 (30%), and 2010–2020 (62%). Most studies were conducted in the USA (47%) or Europe (38%). The median sample size was 58. TTTS was the most common disease group (37% of studies), followed by MMC (23%), and CDH (21%). The most frequently reported sociodemographic variables were maternal age (33%) and gravidity/parity (20%). Race and/or ethnicity was only reported in 12% of studies. Less than 10% of studies reported any other sociodemographic variables. Sociodemographic variables were used as exclusion criteria in 13% of studies. Among studies conducted in the USA, White persons were consistently overrepresented relative to their prevalence in the US disease populations (PPR 1.32–2.11), while Black or African-American, Hispanic or Latino, Asian, American-Indian or Alaska-Native, and Native-Hawaiian or other Pacific Islander persons were consistently underrepresented (PPR 0–0.60). Conclusions: Sociodemographic reporting quality in maternal-fetal surgery studies is poor and inhibits examination of potential health disparities. Participants enrolled in studies in the USA do not adequately represent the racial and ethnic diversity of the population across disease groups.

23 December 2023 in Social Science & Medicine
Verified
Journal Article
Closed access
EHE Goldblatt Hyatt
E Goldblatt Hyatt
AWAbigail Wilpers
Abigail Wilpers
MBMert Ozan Bahtiyar
Mert Ozan Bahtiyar
YHYunzhe Hu
Yunzhe Hu
DLDaisy Leon-Martinez
Daisy Leon-Martinez
JMJudith L.M. McCoyd
Judith L.M. McCoyd

2 July 2025 in Journal of Perinatology
Verified
Journal Article
Open access
PDF file
AWAbigail B. Wilpers
Abigail B. Wilpers
SLScott A. Lorch
Scott A. Lorch
Congenital anomalies, affecting 3–5% of pregnancies annually in the United States, are a leading cause of fetal and infant mortality. Despite advancements in fetal care, disparities in care access, quality, and outcomes persist and remain poorly understood. This perspective introduces the Fetal Condition Care and Outcomes (FCCO) Framework, a conceptual model that integrates contextual, individual, structural, and process-level factors influencing care and outcomes. We build on prior adaptations of Andersen’s Behavioral Model of Health Service Use and the Donabedian Structure, Process, and Outcomes Model, expanding their application from risk-appropriate neonatal care to individuals’ whose pregnancies are complicated by severe fetal conditions. By synthesizing evidence across disciplines, we highlight critical gaps in understanding the drivers of disparities, including barriers to timely diagnosis, variations in counseling practices, and inequities in access to specialized services. This article calls for interdisciplinary research to ensure risk-appropriate, person-centered care for this high-risk population.

15 April 2025 in Health Affairs Scholar
Verified
Journal Article
Open access
AWAbigail B Wilpers
Abigail B Wilpers
KKKathie Kobler
Kathie Kobler
RSRobyn Schafer
Robyn Schafer
MWMelissa Wilpers
Melissa Wilpers
MZMolly Zeme
Molly Zeme
SLScott A Lorch
Scott A Lorch
As abortion care restrictions increase, a growing population is continuing pregnancies complicated by life-limiting fetal conditions, making it more critical than ever to evaluate the state of the evidence in perinatal palliative care (PPC). Perinatal palliative care provides interdisciplinary, person-centered care, integrating medical management with psychosocial and bereavement support to enable values-driven decision-making. This scoping review evaluates US-based evidence on the safety, effectiveness, acceptability, and equity of PPC, assessing how these findings relate to growing abortion restrictions. Analysis of 13 studies found that US PPC programs are understudied, with limited evidence on maternal health and neonatal comfort outcomes. Studies lacked use rates for all eligible individuals, preventing assessment of overall PPC uptake. Most PPC patients reported high satisfaction, citing compassionate care, emotional support, and parental validation. However, studies lacked diversity. None examined the experience of receiving PPC due to abortion restrictions. Existing PPC evidence is limited, leaving critical gaps in safety, effectiveness, acceptability, and equity—key factors in assessing whether PPC meets its intended goals and serves diverse populations. Our review highlights that evidence is insufficient to determine whether PPC can adequately support the growing, vulnerable patient population now directed into it by policy rather than choice.